drugset
drugset / Trial / NCT04965532

Residual Neuromuscular Block of Rocuronium in Chemotherapy Patients Under Sevoflurane Anesthesia

NCT04965532 ↗

Unknown 80 enrolled Second Affiliated Hospital, School of Medicine, Zhejiang University
RandomizedParallel-groupSingle-blindPrevention

Summary

Chemotherapy causes motor nerve dysfunction and degeneration that may alter the response to neuromuscular blocking drugs. To analyse the risk of residual neuromuscular block (RNMB) induced by rocuronium given in standard doses to patients who undergo chemotherapy within three months.

Timeline

Start
2021-09-01
Primary completion
2022-02-28
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule — Intravenous
Subject Sevoflurane Other / unclassified — Inhaled

Indications

chemotherapy-induced toxicity